Bifidobacteria may be beneficial to intestinal microbiota and reduction of bacterial translocation in mice following ischaemia and reperfusion injury

British Journal of Nutrition

Volumn 109, Issue 11, 2013, Pages 1990-1998

  Wang, Honggang ^a   Zhang, Wei ^a   Zuo, Lugen ^a   Zhu, Weiming ^a   Wang, Bin ^a   Li, Qiurong ^a   Li, Jieshou ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

Bacterial translocation; Bifidobacteria; Ischaemia and reperfusion; Microbiota

Indexed keywords

CLAUDIN 1; CYTOKINE; ENDOTOXIN; INTERLEUKIN 6; OCCLUDIN; PROBIOTIC AGENT; PROTEIN ZO1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BACTERIAL TRANSLOCATION; BIFIDOBACTERIUM; BIFIDOBACTERIUM ADOLESCENTIS; BIFIDOBACTERIUM BIFIDUM; BIFIDOBACTERIUM LONGUM; BLOOD; CONTROLLED STUDY; CYTOKINE RELEASE; ENTEROPATHY; ILEUM; INTESTINE BARRIER DYSFUNCTION; INTESTINE EPITHELIUM CELL; INTESTINE FLORA; INTESTINE ISCHEMIA; INTESTINE MUCOSA; INTESTINE ULCER; INTESTINE VILLUS; KIDNEY; LIVER; MALE; MESENTERY LYMPH NODE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REPERFUSION INJURY; SPLEEN; TIGHT JUNCTION;

ANIMALS; BACTERIAL TRANSLOCATION; BIFIDOBACTERIUM; ENDOTOXINS; INTERLEUKIN-6; INTESTINES; MALE; MICE; MICE, INBRED BALB C; RANDOM ALLOCATION; REPERFUSION INJURY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84877970588     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114512004308     Document Type: Article

References (46)

1. Sonnenburg JL, Angenent LT, Gordon JI, et al. (2004) Getting a grip on things: how do communities of bacterial symbionts become established in our intestine. Nat Immunol 5, 569-573.
2. Kelly D, Conway S, Aminov R, et al. (2005) Commensal gut bacteria: mechanisms of immune modulation. Trends Immunol 26, 326-333.
3. Hopkins MJ & Macfarlane GT (2002) Changes in predominant bacterial populations in human faeces with age and with Clostridium difficile infection. J Med Microbiol 51, 448-454.
4. Berg RD & Owens WE (1979) Inhibition of translocation of viable Escherichia coli from the gastrointestinal tract of mice by bacterial antagonism. Infect Immun 25, 820-827.
5. Wells CL, Vande Westerlo EM, Jechorek RP, et al. (1996) Effect of hypoxia on enterocyte endocytosis of enteric bacteria. Crit Care Med 24, 985-991.
6. Kuzu MA, Kale IT, Col C, et al. (1999) Obstructive jaundice promotes bacterial translocation in humans. Hepatogastroen-terology 46, 2159-2164.
7. Ruan X, Shi H, Xia G, Xiao Y, et al. (2007) Encapsulated bifidobacteria reduced bacterial translocation in rats following hemorrhagic shock and resuscitation. Nutrition 23, 754-761.
8. Peitzman AB, Udekwu AO, Ochoa J, et al. (1991) Bacterial translocation in trauma patients. J Trauma 31, 1083-1086.
9. Farhadi A, Banan A, Fields J, et al. (2003) Intestinal barrier: an interface between health and disease. J Gastroenterol Hepatol 18, 479-497.
10. Sun Z, Wang X, Deng X, Borjesson A, et al. (2000) Phago-cytic and intestinal endothelial and epithelial barrier function during the early stage of small intestinal ischemia and reperfusion injury. Shock 13, 209-216.
11. Schoenberg MH, Poch B, Younes M, et al. (1991) Involvement of neutrophils in postischaemic damage to the small intestine. Gut 32, 905-912.
12. Yamamoto S, Tanabe M, Wakabayashi G, et al. (2001) The role of tumor necrosis factor-alpha and interleukin-1beta in ischemia-reperfusion injury of the rat small intestine. J Surg Res 99, 134-141.
13. Ishibashi N & Yamazaki S (2001) Probiotics and safety. Am J Clin Nutr 73, S465-S470.
14. Westerbeek EA, van den Berg A, Lafeber HN, et al. (2006) The intestinal bacterial colonisation in preterm infants: a review of the literature. Clin Nutr 25, 361-368.
15. Salminen S, Bouley C, Boutron-Ruault MC, et al. (1998) Functional food science and gastrointestinal physiology and function. Br J Nutr 80, Suppl. 1, S147-S171.
16. Harmsen HJ, Wildeboer-Veloo AC, Raangs GC, et al. (2000) Analysis of intestinal flora development in breast-fed and formula-fed infants by using molecular identification and detection methods. J Pediatr Gastroenterol Nutr 30, 61-67.
17. Saulnier DM, Spinler JK, Gibson GR, et al. (2009) Mechanisms of probiosis and prebiosis: considerations for enhanced functional foods. Curr Opin Biotechnol 20, 135-141.
18. Fukuda S, Toh H, Hase K, et al. (2011) Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature 469, 543-547.
19. Zhang W, Zhu W, Zhang J, et al. (2008) Protective effects of glucagon-like peptide 2 on intestinal ischemia-reperfusion rats. Microsurgery 28, 285-290.
20. Salazar N, Gueimonde M, Hernandez-Barranco AM, et al. (2008) Exopolysaccharides produced by intestinal Bifidobac-terium strains act as fermentable substrates for human intestinal bacteria. Appl Environ Microbiol 74, 4737-4745.
21. Chiu CJ, McArdle AH, Brown R, et al. (1970) Intestinal mucosal lesion in low-flow states. I. A morphological, hemodynamic, and metabolic reappraisal. Arch Surg 101, 478-483.
22. Mazzon E & Cuzzocrea S (2006) Thalidomide treatment reduces the alteration of paracellular barrier function in mice ileum during experimental colitis. Shock 25, 515-521.
23. Dowdall JF, Winter DC, Bouchier-Hayes DJ, et al. (2002) Ino-sine modulates gut barrier dysfunction and end organ damage in a model of ischemia-reperfusion injury. J Surg Res 108, 61-68.
24. Eror AT, Stojadinovic A, Starnes BW, et al. (1999) Antiinflam-matory effects of soluble complement receptor type 1 promote rapid recovery of ischemia/reperfusion injury in rat small intestine. Clin Immunol 90, 266-275.
25. Luyer MD, Buurman WA, Hadfoune M, et al. (2005) Strain-specific effects of probiotics on gut barrier integrity following hemorrhagic shock. Infect Immun 73, 3686-3692.
26. Deitch EA (2002) Bacterial translocation or lymphatic drainage of toxic products from the gut: what is important in human beings. Surgery 131, 241-244.
27. Moore FA, Moore EE, Poggetti RS, et al. (1992) Postinjury shock and early bacteremia. A lethal combination. Arch Surg 127, 893-897, discussion 897-898.
28. Stecher B & Hardt WD (2001) The role of microbiota in infectious disease. Trends Microbiol 16, 107-114.
29. Dalwai F, Spratt DA, Pratten J, et al. (2006) Modeling shifts in microbial populations associated with health or disease. Appl Environ Microbiol 72, 3678-3684.
30. Fujiwara S, Hashiba H, Hirota T, et al. (1997) Proteinaceous factor(s) in culture supernatant fluids of bifidobacteria which prevents the binding of enterotoxigenic Escherichia coli to gangliotetraosylceramide. Appl Environ Microbiol 63, 506-512.
31. Wang Z, Xiao G, Yao Y, et al. (2006) The role of bifido-bacteria in gut barrier function after thermal injury in rats. J Trauma 61, 650-657.
32. Tedelind S, Westberg F, Kjerrulf M, et al. (2007) Anti-inflammatory properties of the short-chain fatty acids acetate and propionate: a study with relevance to inflammatory bowel disease. World J Gastroenterol 13, 2826-2832.
33. Kles KA & Chang EB (2006) Short-chain fatty acids impact on intestinal adaptation, inflammation, carcinoma, and failure. Gastroenterology 130, Suppl. 1, S100-S105.
34. Maslowski KM, Vieira AT, Ng A, et al. (2009) Regulation of inflammatory responses by gut microbiota and chemoattrac-tant receptor GPR43. Nature 461, 1282-1286.
35. Florent C, Flourie B, Leblond A, et al (1985) Influence of chronic lactulose ingestion on the colonic metabolism of lac-tulose in man (an in vivo study). J Clin Invest 75, 608-613.
36. Pan XD, Chen FQ, Wu TX, et al. (2009) Prebiotic oligosaccharides change the concentrations of short-chain fatty acids and the microbial population of mouse bowel. J Zhejiang Univ Sci B 10, 258-263.
37. Wang B, Huang Q, Zhang W, et al. (2011) Lactobacillus plan-tarum prevents bacterial translocation in rats following ischemia and reperfusion injury. Dig Dis Sci 56, 3187-3194.
38. Grotz MR, Deitch EA, Ding J, et al. (1999) Intestinal cytokine response after gut ischemia: role of gut barrier failure. Ann Surg 229, 478-486.
39. Kurtel H, Fujimoto K, Zimmerman BJ, et al. (1991) Ischemia-reperfusion- induced mucosal dysfunction: role of neutrophils. Am J Physiol 261, G490-G496.
40. Griffiths EA, Duffy LC, Schanbacher FL, et al. (2004) In vivo effects of bifidobacteria and lactoferrin on gut endotoxin concentration and mucosal immunity in Balb/c mice. Dig Dis Sci 49, 579-589.
41. Park SY, Ji GE, Ko YT, et al. (1999) Potentiation of hydrogen peroxide, nitric oxide, and cytokine production in RAW 264.7 macrophage cells exposed to human and commercial isolates of Bifidobacterium. Int J Food Microbiol 46, 231-241.
42. Guarner F & Malagelada JR (2006) Gut flora in health and disease. Lancet 361, 512-519.
43. Zhang LL, Chen X, Zheng PY, et al. (2010) Oral Bifidobacterium modulates intestinal immune inflammation in mice with food allergy. J Gastroenterol Hepatol 25, 928-934.
44. Hebra A, Hong J, McGowan KL, et al. (1994) Bacterial translocation in mesenteric ischemia-reperfusion injury: is dysfunctional motility the link? J Pediatr Surg 29, 280-285, discussion 285-287.
45. Schoenberg MH & Beger HG (1993) Reperfusion injury after intestinal ischemia. Crit Care Med 21, 1376-1386.
46. Harhaj NS & Antonetti DA (2004) Regulation of tight junctions and loss of barrier function in pathophysiology. Int J Biochem Cell Biol 36, 1206-1237.